Searched for
NEURO GENERATIVE DISEASES
Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...- Learn to live with volatility – and still invest: 6 mid-cap stocks from different segments of a sector, with upside potential of up to 47%What is narrative and what is reality? A research report has dropped out of the blue, contending that consumption patterns across the world...
- AI-biotech sovereignty will define India’s futureIndia must lead in biotech sovereignty powered by AI. This convergence will shape healthcare, food, and biosecurity. Nations controlling bi...
- Healthcare stocks: Better to own a basket for a healthy portfolio? 15 healthcare stocks with an upside potential of up to 33%Four years ago, Covid brought hospital stocks to the limelight. Since then, corporate actions like mergers and takeovers have kept them in ...
- GSK's antibiotic drug Augmentin is India's highest-selling brand with Rs 80 crore monthly saleEnhertu, a cancer drug by AstraZeneca, was the top-selling new drug in 2024 with sales of nearly Rs 58 crore. Over 3,100 new brands were la...
- One possible headwind, but multiple tailwinds: 8 stocks from the healthcare ecosystem, 4 with ‘Buy’ & 4 with ‘Hold’ recommendationsWhen valuations across the stock markets are high, one should look for sectors with macro tailwinds. Sectors and stocks with structural tai...
- Alpha generators in the long term: 9 mid and small cap stocks from pharma and healthcare sector with an upside potential of up to 29%While some make it to the headlines, some don't. Two sectors, healthcare and pharma have been witnessing more mergers and acquisitions than...
- Be bullish, just manage risks & desire; 5 midcap stocks for long term investorsIn a bullish market many things change and one of them is the relationship between opportunity and challenges. Given the way markets are pa...
- Will short-term headwinds impact long-term potential? 6 stocks from hospital sector with upside potential of up to 30%After outperforming the market, stocks from the healthcare sector or what is more commonly called hospital sector have gone into consolidat...
- Looking for a healthy portfolio amid volatility? 8 stocks from hospital space with upside scope of up to 27%One sector which has performed extremely well in the last two years has been hospital space. If one looks at the post listing performance o...
- Cognizant extends partnership with biopharma firm Gilead, estimated deal size at $800 millionGilead has partnered with Cognizant for more than three years now to adopt technologies designed to run business operations, new product la...
- Bengaluru scientist bags Shanti Swarup Bhatnagar prizeHis innovative work on small molecules, peptides, and natural products offers both diagnostics as well as therapeutics, leading to personal...
- Double whammy: Coronavirus threat, fear of job lossThe toll-free helpline started by the central government to deal with psycho-social problems faced by people in the wake of Covid-19 crisis...
- Boheco: This cannabis startup is weeding out the high notes for a Hemp economyBoheco is focused on establishing a scale-centric approach towards industrial hemp based products and raw material as well as cannabis-base...
- Graphene electrodes can safely interact with neuronsIt can be used to control robotic armfor amputee patients or any number of basic processes for paralysed patients from speech to movement o...
- Government's role important as pharmaceutical companies hesitate to invest on tropical disease researchEbola, it seems has been around for over 40 years, and periodically has outbreaks in the poorest parts of Africa. And then what?
- Mega Trends - Visions for the near and extreme futureThe future of our lives, of our work, of our businesses - depends on us gaining a new understanding of the dizzying changes that lie ahead.
- Ultrasound is Stethoscope of future: Thomas GentileBehemoth GE’s global head of medical technology Thomas Gentile speaks of the opportunities for healthcare systems & technologies.
- Suven gets European patent for its clinical candidate SUVN-502Pharmaceutical firm Suven Life Sciences on Monday said it has received European product patent for its clinical candidate SUVN-502, valid u...
- Bombay hospital introduces ozone therapy for patientsIn an effort to popularise the non-invasive and cost-effective complementary ozone therapy, Bombay Hospital has started the therapy for peo...
Load More
